MDS Proteomics teams with Agilent Technologies

Guest Contributor
May 28, 2001

Toronto’s MDS Proteomics Inc and Agilent Technologies Inc, Palo Alto CA, have entered an agreement to develop new protein analysis technologies and applications to accelerate the speed of medicine development. MDS will work with Agilent’s Bio-Consumables and Services division, which possesses expertise in separation science and liquid chromotography for identifying and characterizing proteins. MDS will contribute its expertise in protein pathway biology, mass spectrometry analysis and high-performance super computing. The value of the collaboration was not disclosed....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.